Bioinformatics Market is Expected to Reach $18.7 billion … – GlobeNewswire

| Source: MarketsandMarkets Research Pvt. Ltd. MarketsandMarkets Research Pvt. Ltd.
SEZ Magarpatta City, INDIA
Chicago, April 14, 2023 (GLOBE NEWSWIRE) — The bioinformatics industry is expected to experience tremendous growth in the near future as advances in technology and genetics allow for more efficient data analysis. The use of artificial intelligence, machine learning, and big data analytics are expected to increase, leading to more efficient and accurate data analysis. Additionally, the growth of the bioinformatics industry will be driven by the increased demand for personalized medicine, as well as the need for more efficient and accurate diagnostics and treatments. As the industry matures, new partnerships between healthcare providers, pharmaceutical companies, and bioinformatics companies are expected to form, leading to more opportunities for both collaboration and competition. Finally, the development of cloud-based solutions for bioinformatics will enable more efficient data sharing and analysis. All in all, the near future of the bioinformatics industry looks very promising.
Bioinformatics market in terms of revenue was estimated to be worth $10.1 billion in 2022 and is poised to reach $18.7 billion by 2027, growing at a CAGR of 13.0% from 2022 to 2027 according to a latest report published by MarketsandMarkets™. Bioinformatics used in computer technology for the management and analysis of intricate biological data. Storage, analysis, and dissemination of biological data is part of this process. However, the high cost of equipment is hindering the growth of this market.
Download an Illustrative overview:
Bioinformatics Market Scope:
On basis of product & services, the bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. In 2021, the knowledge management tools segment accounted for the largest share of 36.3% of the bioinformatics market. The large share of this segment is attributed to the growing demand for knowledge management tools to manage large volumes of data generated in life science research and drug discovery. However, the bioinformatics services segment is estimated to be the fastest-growing segment during the forecast period. The need to reduce sequencing costs and manage growing data volumes, as well as the growing government funding for genomics research, are responsible for the growth of this market segment.
On basis of application, the bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and other applications. In 2021, Genomics segment accounted for the largest share of 36.9% of the bioinformatics market. The constant rise in use of pharmacogenomic research for the development of precision medicine, the favourable funding scenario for genomic research, and strategic partnerships between various life sciences and informatics companies for the development of technologically advanced bioinformatics solutions and services are the major factors owing to the growth of the bioinformatics market for genomics segment.
On basis of sector, the bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other sectors (which include food, homeland security & defense, law enforcement, bioweapon creation, and evolutionary biotechnology). The medical biotechnology segment commanded the largest share of the bioinformatics market in 2021. The large share of this segment can be attributed to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and the increased funding for the development of bioinformatics solutions for clinical diagnostics.
The bioinformatics market has been segmented into four main regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America accounted for the largest market share of 45.1%. However, the Asia Pacific market is projected to register the highest CAGR of 14.7% during the forecast period. The Asia Pacific region is expected to offer significant opportunities for players to offset revenue losses incurred in mature markets. Emerging countries in this region are witnessing growth in their GDPs and a significant rise in disposable income levels.
Key Market Players:
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.
Enquiry Before Buying:
Hypothetic Challenges of Bioinformatics Market in Near Future:
Top 3 Use Cases of Bioinformatics Market:
Get 10% Free Customization on this Report:
Recent Developments:
Related Reports:
Next Generation Sequencing Market
eClinical Solutions Market
Gene Therapy Market
Bioinformatics Services Market
Drug Discovery Informatics Market


Leave a Comment